Xofigo (radium Ra-223 dichloride)

News alerts, weekly reports and conference planners

Company:

Bayer

Drug class:

Alpha radiation emitter

Related drugs:

TMPRSS2-ERG fusion	Prostate Cancer	TMPRSS2-ERG fusion	Prostate Cancer	radium Ra-223 dichloride Resistant: C2 – Inclusion Criteria radium Ra-223 dichloride Resistant : C2	radium Ra-223 dichloride Resistant: C2 – Inclusion Criteria radium Ra-223 dichloride Resistant : C2
RB deletion	Prostate Cancer	RB deletion	Prostate Cancer	radium Ra-223 dichloride Resistant: C3 – Early Trials radium Ra-223 dichloride Resistant : C3	radium Ra-223 dichloride Resistant: C3 – Early Trials radium Ra-223 dichloride Resistant : C3

Associations
(2)